指南与共识创伤与烧伤心脑血管急症消化、代谢与肾脏急症

生物标志物S100B的诊断效能与轻型颅脑创伤常规诊疗中的指南依从性

Diagnostic performance of biomarker S100B and guideline adherence in routine care of mild head trauma.
指南 / 共识 · Scand J Trauma Resusc Emerg Med · 2023-01-10
一句话结论常规诊疗中S100B在指南推荐的SNC 4类患者中敏感性100%、阴性预测值100%,可用于安全排除创伤性颅内出血,但超指南使用则敏感性降至93%。

本研究回顾性分析瑞典赫尔辛堡医院急诊科连续收治的1671例18岁以上孤立性颅脑创伤患者,评估斯堪的纳维亚神经创伤委员会(SNC)指南的依从性及血清S100B的诊断效能。结果显示颅内出血93例(5.6%),62%患者接受CT检查,26%患者检测S100B,其中仅30%的检测针对指南推荐的低风险轻型颅脑创伤(SNC 4)。S100B推荐截断值(≥0.10 µg/L)用于SNC 4类患者时敏感性100%、特异性47%、阳性预测值10.1%、阴性预测值100%;用于所有检测患者时对创伤性颅内出血的敏感性为93%。当前急诊实践指南依从率为55%,低风险轻型颅脑创伤(SNC 4)患者中64%存在不依从(S100B和CT过度或不足检测)。作者认为,在指南推荐的患者类别中检测S100B可安全排除创伤性颅内出血,而在非推荐患者中检测则敏感性低至不可接受,可能导致漏诊。

要点

  • 对SNC 4类低风险轻型颅脑创伤患者,血清S100B以≥0.10 µg/L为截断值排除创伤性颅内出血的敏感性100%、阴性预测值100%。
  • 在指南未推荐的患者中检测S100B,对创伤性颅内出血的敏感性降至93%,可能导致漏诊。
  • 常规急诊实践中仅55%患者完全遵循SNC指南,SNC 4患者中64%存在S100B或CT的过度检测或检测不足。
  • 指南依从性与更高的入院率相关,但不依从与漏诊创伤性颅内出血或死亡无显著增加相关。
  • 作者认为需更多研究来明确不依从的程度和影响。

适用人群与场景

  • 连续就诊于赫尔辛堡医院急诊科、年龄18岁及以上、孤立性颅脑创伤的患者。
  • 排除多发伤、随访就诊以及由护士处理而无医生参与的患者。

诊断标准与关键阈值

  • S100B推荐截断值为≥0.10 µg/L。
  • SNC指南推荐对低风险轻型颅脑创伤(SNC 4)患者使用血清S100B。

研究设计与关键结果

  • 共纳入1671例患者,93例(5.6%)存在颅内出血,62%患者接受了CT检查。
  • 26%患者检测了S100B,其中仅30%的检测针对指南推荐的低风险轻型颅脑创伤。
  • S100B截断值≥0.10 µg/L用于SNC 4类患者时:敏感性100%、特异性47%、阳性预测值10.1%、阴性预测值100%。
  • S100B用于所有检测患者时,对创伤性颅内出血的敏感性为93%。
  • 当前急诊实践对SNC指南的依从率为55%;SNC 4患者中64%存在不依从,包括S100B和CT的过度检测或检测不足。
  • 指南依从性与更高的入院率相关,但不依从与漏诊创伤性颅内出血或死亡无显著增加相关。

证据类型、等级与局限

  • 证据类型:基于医院记录的回顾性队列研究(连续患者)。
  • 局限:作者指出需更多研究来明确不依从的程度和影响(原文:To further delineate the magnitude and impact of non-adherence, more studies are needed)。

对床旁实践的改变

  • 对SNC 4类低风险轻型颅脑创伤患者,按指南检测血清S100B(截断值≥0.10 µg/L)可安全排除创伤性颅内出血,敏感性和阴性预测值均达100%。
  • 在指南未推荐的患者中检测S100B敏感性仅93%,可能导致漏诊创伤性颅内出血。
  • 当前实践中SNC 4患者64%存在S100B或CT的过度检测或检测不足,提示需改善指南依从性。
  • 不依从指南与更高的入院率相关,但未发现漏诊创伤性颅内出血或死亡显著增加。
  • 作者认为需更多研究来明确不依从的程度和影响。

指南或共识出处

  • 斯堪的纳维亚神经创伤委员会(SNC)指南

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The Scandinavian Neurotrauma Committee (SNC) has recommended the use of serum S100B as a biomarker for mild low-risk Traumatic brain injuries (TBI). This study aimed to assess the adherence to the SNC guidelines in clinical practice and the diagnostic performance of S100B in patients with TBI. The aims of this study were to examine adherence to the SNC guideline and the diagnostic accuracy of serum protein S100B.

METHODS: Data of consecutive patients of 18 years and above who presented to the emergency department (ED) at Helsingborg Hospital with isolated head injuries, were retrieved from hospital records. Patients with multitrauma, follow-up visits, and visits managed by a nurse without physician involvement were excluded.

RESULTS: A total of 1671 patients were included of which 93 (5.6%) had intracranial hemorrhage. CT scans were performed in 62% of patients. S100B was measured in 26% of patients and 30% of all measurements targeted the low-risk mild head injuries indicated by the guideline. S100B's recommended cut-off value (≥ 0.10 µg/L) had a 100% sensitivity, 47% specificity, 10.1% positive predictive value, and 100% negative predictive value-if applied to the target SNC category (SNC 4). If applied to all patients tested, the sensitivity was 93% for traumatic intracranial hemorrhage (TICH). Current ED practices were adherent to the SNC guideline in 55% of patients. Non-adherent practices occurred in 64% of patients with low-risk mild head injuries (SNC4) including overtesting or undertesting of S100B and CT scans.

CONCLUSION: Adherence to guidelines was low and associated with a higher admission rate than non-adherence practice but no significant increase in missed TICH or death associated with non-adherence to guideline was found. In routine care, we found that the sensitivity and NPV of serum protein S100B was excellent and safely ruled out TICH when measured in the patient category recommended by the guideline. However, measuring serum protein S100B in patients not recommended by the guideline rendered unacceptably low sensitivity with possible missed TICHs as a consequence. To further delineate the magnitude and impact of non-adherence, more studies are needed.

来源:Scand J Trauma Resusc Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Faisal M, Vedin T, Edelhamre M, et al. Diagnostic performance of biomarker S100B and guideline adherence in routine care of mild head trauma. Scand J Trauma Resusc Emerg Med. 2023. PMID: 36624501. doi:10.1186/s13049-022-01062-w

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。